3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3

PloS One
Jonas Aakre WikJohanna Hol

Abstract

Inhibition of the key glycolytic activator 6-phosphofructokinase 2/fructose-2,6-bisphosphatase-3 (PFKFB3) by 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) strongly attenuates pathological angiogenesis in cancer and inflammation. In addition to modulating endothelial proliferation and migration, 3PO also dampens proinflammatory activation of endothelial cells and experimental inflammation in vivo, suggesting a potential for 3PO in the treatment of chronic inflammation. The aim of our study was to explore if the anti-inflammatory action of 3PO in human endothelial cells was mediated by inhibition of PFKFB3 and glycolysis and assess if other means of PFKFB3 inhibition reduced inflammatory activation in a similar manner. We found that 3PO caused a rapid and transient reduction in IL-1β- and TNF-induced phosphorylation of both IKKα/β and JNK, thus inhibiting signaling through the NFκB and the stress-activated kinase pathways. However, in contrast to 3PO-treatment, neither shRNA-mediated silencing of PFKFB3 nor treatment with the alternative PFKFB3 inhibitor 7,8-dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-one (YN1) prevented cytokine-induced NFκB signaling and upregulation of the adhesion molecules VCAM-1 and E-selectin, implying...Continue Reading

References

Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·C J EdgellJ B Graham
Apr 1, 1996·Virchows Archiv : an International Journal of Pathology·A J Staal-van den BrekelE F Wouters
Jun 22, 2001·Experimental and Molecular Pathology·L A Madge, J S Pober
Jul 19, 2001·Nature·C WangZ J Chen
May 29, 2009·The Journal of Biological Chemistry·Abdullah YalcinJason Chesney
Mar 20, 2010·Cold Spring Harbor Perspectives in Biology·Alain Israël
Feb 4, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Veronika MakóLászló Cervenak
Nov 20, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Jürgen PollheimerJohanna Hol
May 16, 2013·Molecular Cancer Therapeutics·Brian F ClemJason Chesney
Aug 6, 2013·Cell·Katrien De BockPeter Carmeliet
Apr 5, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Yiming XuYuqing Huo
Apr 18, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Ahmed TawakolLisardo Boscá
Mar 26, 2016·Annals of the Rheumatic Diseases·M BinieckaU Fearon
Jul 12, 2016·Nature Reviews. Immunology·Luke A J O'NeillJeff Rathmell
Sep 7, 2017·Angiogenesis·Lena-Christin ConradiPeter Carmeliet

❮ Previous
Next ❯

Citations

Mar 30, 2021·Frontiers in Cell and Developmental Biology·Zi-Yi ZhouGuo-Rui Dou

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
ELISA

Software Mentioned

Primer3
GraphPad Prism
Image Lab

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.